Immunitas Therapeutics

Approach

Immunitas Therapeutics employs a single cell genomics platform to dissect the biology of immune cells in human tumors. They identify novel, exciting oncology targets and, importantly, developing key biomarkers to guide the selection of patients who may benefit from their new drugs.

Immunitas Therapeutics is addressing

• Leap 04 / Prevent and cure cancer